medigraphic.com
SPANISH

Revista Cubana de Farmacia

ISSN 1561-2988 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 3

<< Back Next >>

Rev Cubana Farm 2021; 54 (3)

Validation of an analytical method for the titration of injectable lyophilized Amphotericin B

Valdés PT, Romeu CCR, Ramírez TG
Full text How to cite this article

Language: Spanish
References: 11
Page: 1-11
PDF size: 682.40 Kb.


Key words:

HPLC/methods, Amphotericin B, validation.

ABSTRACT

Introduction: The injectable lyophilized Amphotericin B is used as an antifungal against a wide spectrum of fungi.
Objective: Validate an analytical method by high-performance liquid chromatography for the titration of the injectable lyophilized Amphotericin B.
Methods: The method was based on the separation of the active substance through an Apollo-C18 chromatographic column (5 μm) (250 x 4.6 mm), with ultraviolet detection at 380 nm, for which a mobile phase composed of a mixture of 650 mL of Acetonitrile: Methanol: Tetrahydrofuran (39:17:9) and 350 mL of EDTA Buffer (2.5 mmol/L) was used, with a flow rate of 1.5mL/min. The calibration curve was performed in the range of 0.01 mg/mL to 0.03 mg/mL, (from 50% to 150% of the amount proposed in the technique).
Results: The method was linear, with a correlation coefficient equal to 0.9998; the statistical test for interception and slope was considered non-significant. A recovery of 100.48% was obtained in the range of concentrations studied and the Cochran and Student's t tests were not significant. The coefficient of variation in the repeatability study was equal to 0.07% for the 6 replicates tested, while in the intermediate precision analyses the Fischer and Student's t tests were not significant. In the specificity study, no interference from additional peaks was observed near the retention time of the main product. The analytical method was linear, precise, specific and accurate in the range of concentrations studied.
Conclusions: The analytical method validated by high-performance liquid chromatography for the quantification of the active ingredient of the injectable lyophilized Amphotericin B, turned out to be linear, precise, accurate and specific, in the range of concentrations established between 0.01 mg/mL and 0.03 mg/mL.


REFERENCES

  1. Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-nationalprevalence of fungal diseases–estimate precision. Journal of Fungi. 2017;3:57.DOI: 10.3390/jof3040057

  2. Vallabhaneni S, Mody RK, Walker T, Chiller T. The global burden of fungaldiseases. Journal of Infectious Disease Clinics. 2016;30:1-11. DOI:10.1016/j.idc.2015.10.004

  3. Nett JE, Andes DR. Antifungal agents: Spectrum of activity, pharmacology,and clinical indications. Journal of Infectious Disease Clinics. 2016;30:51-83.DOI: 10.1016/j.idc.2015.10.012

  4. Montagna MT, Lovero G, Coretti C, De Giglio O, Martinelli D, Bedini A, et al. Invitro activities of amphotericin B deoxycholate and liposomal amphotericin Bagainst 604 clinical yeast isolates. Journal of Medical Microbiology.2014;63:1638-43. DOI: 10.1099/jmm.0.075507-0

  5. Faustino C, Pinheiro L. Lipid Systems for the Delivery of Amphotericin B inAntifungal Therapy. International Journal of Pharmaceutics. 2020;12:29.DOI:10.3390/pharmaceutics12010029

  6. Azmat AK, Mumtaz J, Amer MA, Abdul AK. Antifungal efficacy of amphotericinB encapsulated fibrin microsphere for treating Cryptococcus neoformansinfection in Swiss albino mice. The Brazilian Journal of Infectious Diseases.2016;20(4):342-48.DOI: 10.1016/j.bjid.2016.04.006

  7. Baibek A, Üçüncü M, Short B, Ramage G, Lilienkampf A, Bradley M. Dyeingfungi: amphotericin B based fluorescent probes for multiplexed imaging.Chemical Communication Journal. 2021;57(15):1899-1902. DOI:10.1039/D0CC08177A

  8. Colectivo de autores. Validation of Analytical Procedures. TechnicalRequirements for the Registration of Pharmaceuticals for Human Use. Geneva:International Conference on Harmonization ICH-Q2A; 1995.

  9. The United States Pharmacopeial Convention. Farmacopea de los EstadosUnidos. 42 ed. Estados Unidos de América NF-37. Rockville: Mack Printing; 2019.

  10. Centro para el Control Estatal de Medicamentos, Equipos y DispositivosMédicos. Resolución No 40/2014. Anexo No. I de la Regulación No 37/2012,Buenas Prácticas para Laboratorios de Control de Medicamentos. Validación deMétodos Analíticos. La Habana: CECMED; 2014.

  11. Quattrocchi OA, Laba RF. Introducción a la HPLC en Aplicación y práctica.Buenos Aires: Ed. Artes Gráficas Farro, 1992 p. 106-122, 284, 302-328.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Farm. 2021;54